# Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol

> **NCT00830882** · PHASE4 · WITHDRAWN · sponsor: **University of Dundee**

## Conditions studied

- Asthma

## Interventions

- **DRUG:** levosalbutamol
- **DRUG:** racemic salbutamol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00830882
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-01
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2012-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830882, "Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00830882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*